The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

ASCO 2019 | NSCLC treatment

Name: NSCLC treatment
Uploaded: 2019-06-02T00:00:00Z
Duration: 1 min 57 s
Description: Vanita Noronha, MBBS, MD, DM, of the Tata Memorial Center, Mumbai, India, outlines the treatment of non-small cell lung cancer (NSCLC) and where the treatment of the disease is moving at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Vanita Noronha • 2 Jun 2019

ASCO 2019

Lung Cancer Gefitinib

Vanita Noronha, MBBS, MD, DM, of the Tata Memorial Center, Mumbai, India, outlines the treatment of non-small cell lung cancer (NSCLC) and where the treatment of the disease is moving at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.